IP Library Granted Patent US 8,012,750
Granted Patent B2
US 8,012,750 · App. 12/533,668 · Granted Sep 6, 2011

T-cell activation device

Assignee: Immunovative Therapies Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,012,750
App. No.
12/533,668
Granted
Sep 6, 2011
Kind
B2
Abstract

A biodegradable device for activating T-cells includes a biodegradable support and a binder attached to the biodegradable support, the binder having reactivity to one or more agents capable of binding to a T-cell surface antigen.

Claims (11)

1. A method for activating T-cells comprising:

attaching more than one second material to a population of T-cells; and

mixing the T-cells with a support with an attached first material, wherein the first material is capable of cross-linking the more than one second material.

2. The method of claim 1 wherein the first material comprises polyclonal or monoclonal antibodies, or fragments thereof, protein A, avidin or biotin.

3. The method of claim 1 wherein the first material is attached to the support with glutaraldehyde.

4. The method of claim 1 wherein the first material is initially attached to the support prior to mixing with the T-cells.

5. The method of claim 4 and further applying a blocking agent to the first material after attachment to the support, the blocking agent to be used for blocking non-specific absorption of proteins.

6. The method of claim 1 wherein the second materials comprise mitogenic proteins, monoclonal antibodies, fusion proteins, materials capable of binding to chemokine receptors or combinations thereof.

7. The method of claim 6 wherein the mitogenic proteins include anti-CD3 and anti-CD2 monoclonal antibodies.

8. The method of claim 1 wherein the support is a biodegradable support.

9. The method of claim 8 wherein the biodegradable support is made of a biodegradable material formed into a substantially spherically configuration.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ADDRESS OS THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 050489 FRAME: 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM IMMUNOVATIVE THERAPIES, LTD. TO MICHAEL HAR-NOY ON THE ORIGINAL COVER SHEET PREVIOUSLY RECORDED ON REEL 050489 FRAME 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
RESCISSION Recorded Sep 12, 2019
From: HAR-NOY, MICHAEL
To: HAR-NOY, MICHAEL
Reel/Frame 050467/0081 →
Continuity (4)
Division 11601446 · Nov 17, 2006
Continuation In Part 11066133 · Feb 24, 2005
Provisional Application 60547966 · Feb 26, 2004
Related Publication 20090291498A1 · Nov 26, 2009